$PEN News

Penumbra Inc (NYSE:PEN) Shows Strong Growth and Bullish Technical Setup

Citigroup Maintains Neutral on Penumbra, Lowers Price Target to $350

Evercore ISI Group Maintains Outperform on Penumbra, Lowers Price Target to $335

Assessing Penumbra (PEN) Valuation As Growth Expectations Meet A Premium P/E Multiple

Penumbra (PEN) Misses Q1 Earnings Estimates

Penumbra Q1 Adj. EPS $1.00 Misses $1.07 Estimate, Sales $374.758M Beat $371.104M Estimate

ALC vs. PEN: Which Stock Should Value Investors Buy Now?

NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry

3 Reasons Why Penumbra (PEN) Is a Great Growth Stock

Boston Scientific Corporation (BSX) Price Target Lowered at Mizuho Ahead of Q1 Medical Device Earnings

Penumbra Inc (NYSE:PEN) Presents a Compelling Growth and Breakout Opportunity

Peninsula Energy Limited (ASX:PEN): When Will It Breakeven?

New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients

3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)

Penumbra (NYSE:PEN): Strongest Q4 Results from the Medical Devices & Supplies - Cardiology, Neurology, Vascular Group

2 Reasons to Avoid PEN and 1 Stock to Buy Instead

Assessing Penumbra (PEN) Valuation As Shares Trade On A High P/E Multiple

Penumbra (PEN) Down 1.6% Since Last Earnings Report: Can It Rebound?

Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates

Penumbra Inc (NYSE:PEN) Combines Strong Growth with Bullish Chart Setup